Quest Diagnostics Inc (NYSE:DGX)
| 121.85 Delayed Data As of Sep 29 |  -1.50 / -1.22%Today’s Change | 121.73 Today|||52-Week Range 158.34 | -22.11% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Rusckowski Stephen H Director |  Gift | 3/06/2023 | 82,631 | $147.86 | $12.2M | -13.16% |
Rusckowski Stephen H Director |  Sale | 3/06/2023 | 38,604 | $147.86 | $5.7M | -13.16% |
Doherty Catherine T | Buy | 11/28/2022 | 40,765 | $86.63 | $3.5M | -18.25% |
Doherty Catherine T | Sale | 11/28/2022 | 23,407 | $149.37 | $3.5M | -18.25% |
Doherty Catherine T | Sale | 11/28/2022 | 17,358 | $148.92 | $2.6M | -18.25% |
Davis James E /quest/ President & Chief Executive Officer | Gift | 3/06/2023 | 15,204 | $147.86 | $2.2M | -13.16% |
Deppe Michael Joseph Chief Administrative Officer & Controller | Sale | 10/26/2022 | 15,497 | $145.00 | $2.2M | -15.09% |
Doherty Catherine T | Gift | 3/06/2023 | 9,917 | $147.86 | $1.5M | -13.16% |
Prevoznik Michael E General Counsel & Senior Vice President | Gift | 3/06/2023 | 8,595 | $147.86 | $1.3M | -13.16% |
Davis James E /quest/ President & Chief Executive Officer | Sale | 3/06/2023 | 8,036 | $147.86 | $1.2M | -13.16% |
Page of 9